ArticleBMC biotechnology2026

B3GNT6 suppresses colorectal cancer progression by inhibiting the KRAS/ERK signaling pathway.

Changwen Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.